Liam Smeeth MBChB FRCGP FFPH FRCP MSc PhD
About Liam Smeeth
Head of the Department of Non-Communicable Disease Epidemiology
- Liam Smeeth's Contacts
- Keppel Street
- WC1E 7HT
- T: 020 7927 2296
- F: 020 7580 6897
Liam Smeeth's Background
I trained in medicine and continue to do clinical work as a general practitioner in north London. I joined LSHTM in 1999 and hold a Wellcome Trust senior research fellowship in clinical science. I am Deputy Director of the UCL Partners Farr Institute for e Health Research. As well as academic and clinical work I am involved in a range of activities for the National Institute of Health and Care Excellence (NICE), the Medicines and Healthcare Products Regulatory Agency (MHRA) and the UK National Health Service more widely.
Liam Smeeth's Affiliation
Liam Smeeth's Teaching
I am involved in wide range of teaching activities and was previously course director of the MSc epidemiology and then chair of the exam board.
Liam Smeeth's Research
My major interests are in disease aetiology and drug treatments. Two key elements of this work are the use of clinical data derived from primary care for epidemiological research, and utilising genetic research to inform our knowledge of the underlying causes of disease. I also have an interest in non-communicable disease epidemiology in low-income countries, with a particular focus on cardiovascular disease. Examples of recently completed projects include studies establishing that acute infection could trigger both arterial and venous vascular events and work on environmental triggers of myocardial infarction. I have an on-going interest in pharmacoepidemiology, particularly around cardiovascular drugs. For example, we recently demonstrated an increased risk of stroke associated with exposure to anti-psychotic drugs. Other interests include intervention trials, systematic reviews and health inequalities.
- Clinical databases
- Primary care
- Randomised controlled trials
- Systematic reviews
- Genetic epidemiology
Disease and Health Conditions
- Cardiovascular disease
- Eye diseases
- Sub-Saharan Africa (all income levels)
- United Kingdom
Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults.
Bhaskaran, K.; Douglas, I.; Forbes, H.; dos-Santos-Silva, I.; Leon, D.A.; Smeeth, L.;
Lancet, 2014; 384(9945):755-65
Tackling non-communicable diseases in low- and middle-income countries: is the evidence from high-income countries all we need?
Ebrahim, S. ; Pearce, N. ; Smeeth, L. ; Casas, J.P. ; Jaffar, S. ; Piot, P. ;
PLoS Med, 2013; 10(1):e1001377
Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designs.
Douglas, I.J. ; Evans, S.J. ; Hingorani, A.D. ; Grosso, A.M. ; Timmis, A. ; Hemingway, H. ; Smeeth, L. ;
BMJ, 2012; 345:e4388
Heat and risk of myocardial infarction: hourly level case-crossover analysis of MINAP database.
Bhaskaran, K. ; Armstrong, B. ; Hajat, S. ; Haines, A. ; Wilkinson, P. ; Smeeth, L. ;
BMJ, 2012; 345:e8050
Validation and validity of diagnoses in the General Practice Research Database: a systematic review.
Herrett, E.; Thomas, S.L.; Schoonen, W.M.; Smeeth, L.; Hall, A.J.;
Br J Clin Pharmacol, 2010; 69(1):4-14
Invasive dental treatment and risk for vascular events: a self-controlled case series.
Minassian, C.; D'Aiuto, F.; Hingorani, A.D.; Smeeth, L.;
Ann Intern Med, 2010; 153(8):499-506
MMR vaccination and pervasive developmental disorders: a case-control study.
Smeeth, L.; Cook, C.; Fombonne, E.; Heavey, L.; Rodrigues, L.C.; Smith, P.G.; Hall, A.J.;
Lancet, 2004; 364(9438):963-9
Risk of Myocardial Infarction and Stroke after Acute Infection or Vaccination.
Smeeth, L.; Thomas, S.L.; Hall, A.J.; Hubbard, R.; Farrington, P.; Vallance, P.;
N Engl J Med, 2004; 351(25):2611-2618
- → View all Liam Smeeth's publications